Is Mohini Health overvalued or undervalued?

As of 23 September 2025, the valuation grade for Mohini Health has moved from attractive to expensive, indicating a shift in market perception. The company is currently deemed overvalued based on its financial ratios. Key metrics include a PE ratio of 15.96, an EV to EBITDA of 9.55, and a Price to Book Value of 0.94.
In comparison to its peers, Mohini Health's PE ratio is significantly lower than that of Altius Telecom, which stands at 54.74, while its EV to EBITDA is more favorable than some of its competitors like Embassy Office REIT at 21.58. Despite these comparisons, the overall valuation suggests that Mohini Health is overvalued in the current market context. Additionally, the company's stock has underperformed relative to the Sensex over the past year, further reinforcing the notion of overvaluation.